[Pharmacologic aspects of the problem of emotional stress].
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects; D001569:Benzodiazepines; D001921:Brain / Q000187:drug effects; D002090:Butyrophenones / Q000494:pharmacology; D002415:Cats; D003220:Conflict, Psychological / Q000187:drug effects; D003463:Cues; D004027:Diencephalon / Q000187:drug effects; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D004644:Emotions / Q000187:drug effects; D006801:Humans; D008636:Mesencephalon / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010465:Perception / Q000187:drug effects; D010640:Phenothiazines; D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000494:pharmacology*; D012054:Reinforcement, Psychology / Q000187:drug effects; D012653:Self Stimulation / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013315:Stress, Psychological / Q000187:drug effects
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D002090:Butyrophenones; D010640:Phenothiazines; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine
Farmakologicheskie aspekty v probleme émotsional'nogo stressa